Helping clients maximize potential, minimize risk is the mission of
Quintiles Consulting
RESEARCH TRIANGLE PARK, N.C., Oct. 8 /PRNewswire/ -- Quintiles
Transnational Corp. today announced the appointment of Jay D. Norman to
serve as President of its expanding Quintiles Consulting business, which
helps pharmaceutical, biotech and medical device companies maximize
potential and minimize risk from early discovery through commercialization.
Quintiles is investing in the growth of its consulting business to help
meet the needs of its customers as they face increasingly complex
regulatory, development and market challenges. Building on its current
practice areas and the global reach and expertise of its parent company,
Quintiles Consulting's offerings will encompass strategic product
development, regulatory compliance, and pricing and reimbursement.
"As the world's largest CRO, Quintiles is uniquely positioned to
provide our consulting clients with competitive advantages and insight as
they navigate the development process and look to expand the financial and
therapeutic potential of their products," said John Ratliff, Quintiles
Transnational Chief Operating Officer. "With Jay's experience in developing
consultancies, and the industry and former FDA experts we already have on
staff, Quintiles is poised to expand its footprint in the consulting
arena."
Norman brings 25 years of experience in the consulting industry and a
strong track record of growth, most recently with Diamond Management and
Technology Consultants, where he served as President and Chief Operating
Officer. Norman's accomplishments at Diamond earned him recognition by
Consulting Magazine, which named him a "Top 25 Consultant" in 2006.
Norman's diverse background also includes positions of increasing
leadership responsibility at top firms such as PricewaterhouseCoopers
Consulting, McKinsey and Company, Inc. and Accenture.
"Quintiles Consulting is already recognized for its outstanding client
service and insight in providing practical solutions to regulatory
challenges," Norman said. "With the strategic investment Quintiles is
making in consulting services and the reputation we have from our existing
practices, we are well-positioned to become the premier global provider of
strategic consulting to the life sciences industry."
Quintiles Consulting has consultants based across the U.S. and Europe
to serve its global clients.
About Quintiles Transnational
Quintiles Transnational Corp. is powering the next generation of
healthcare by providing a broad range of professional services in drug
development, financial partnering and commercialization for the
pharmaceutical, biotechnology and healthcare industries. With 19,000
employees and offices in more than 50 countries, it is focused on providing
customers with solutions that are the gold standard of the industry. For
more information, please visit the company's Web site at http://www.qtrn.com.
SOURCE Quintiles Transnational Corp.
 back to top
Related links:
http://www.qtrn.com
CONTACT:
Rachael Tarleton Fones, Media Relations,
+1-919-998-2136, media.info@quintiles.com, or Greg Connors,
Investor Relations, +1-919-998-2000, invest@quintiles.com, both
of Quintiles Transnational Corp.
|
